Effecting clinical starting material quality and the impact to downstream processing

Authors

• Dominic Clark, Global Head of Cell Therapy, HemaCare Corporation, USAFollow

Conference Dates

January 27-31, 2019

Abstract

No Abstract.

Recommended Citation

Dominic Clark, "Effecting clinical starting material quality and the impact to downstream processing" in "Advancing Manufacture of Cell and Gene Therapies VI [2019]", Dolores Baksh, GE Healthcare, USA Rod Rietze, Novartis, USA Ivan Wall, Aston University, United Kingdom Eds, ECI Symposium Series, (2019). https://dc.engconfintl.org/cell_gene_therapies_vi/85